Items where Author is "Urbach, H."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Other
Number of items: 2.

Other

Herrlinger, U. and Schaefer, N. and Steinbach, J. P. and Weyerbrock, A. and Hau, P. and Goldbrunner, R. and Leutgeb, B. and Urbach, H. and Stummer, W. and Glas, M. (2014) THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL SURVIVAL RESULTS AND QUALITY OF LIFE. OXFORD UNIV PRESS INC, CARY.

Herrlinger, U. and Schaefer, N. and Steinbach, J. P. and Weyerbrock, A. and Hau, P. and Goldbrunner, R. and Kohnen, R. and Urbach, H. and Stummer, W. and Glas, M. (2013) Bevacizumab, irinotecan and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: Updated results from the randomized multicenter GLARIUS trial. ELSEVIER SCI LTD, OXFORD.

This list was generated on Sat Aug 22 06:41:38 2026 CEST.